APA (7th ed.) Citation

Kim, M., Park, G. S., Lee, K. Y., Moon, S. W., & Sung, Y. E. Role of TP53 Mutations and EGFR Amplification in Risk Stratification of Early‐Stage EGFR‐Mutated Non‐Small Cell Lung Cancer With Immunohistochemistry as a Surrogate Marker. Wiley.

Chicago Style (17th ed.) Citation

Kim, Meejeong, Gyeong Sin Park, Kyo Young Lee, Seok Whan Moon, and Yeoun Eun Sung. Role of TP53 Mutations and EGFR Amplification in Risk Stratification of Early‐Stage EGFR‐Mutated Non‐Small Cell Lung Cancer With Immunohistochemistry as a Surrogate Marker. Wiley.

MLA (9th ed.) Citation

Kim, Meejeong, et al. Role of TP53 Mutations and EGFR Amplification in Risk Stratification of Early‐Stage EGFR‐Mutated Non‐Small Cell Lung Cancer With Immunohistochemistry as a Surrogate Marker. Wiley.